BioHealth News Archive

Viela Bio begins clinical trials months after $250M spinoff – Maryland Daily Record

Viela Bio begins clinical trials months after $250M spinoff – Maryland Daily Record

One of Maryland’s best-funded biotech companies took a milestone first step Monday, announcing it has begun clinical trials of a medication it is developing. Gaithersburg-based Viela…

Read More
AAVogen Expands Science Advisory Board, Completes Another Milestone – PRESS RELEASE

AAVogen Expands Science Advisory Board, Completes Another Milestone – PRESS RELEASE

AAVogen Inc., a biotech company that is developing gene therapeutics for muscle wasting disease, welcomes Lawson Macartney, DVM/PhD as the newest member of its…

Read More
MCEDC Success Series: MedImmune and Bio Excellence

MCEDC Success Series: MedImmune and Bio Excellence

MedImmune is one of the 300+ BioHealth success stories in Montgomery County. Meet JoAnn Suzich, Ph.D., VP of Research and Microbial Sciences, who shares…

Read More
Life Science Nation Fundraising Bootcamp 8/27 OR 8/28

Life Science Nation Fundraising Bootcamp 8/27 OR 8/28

Are you seeking funding or about to launch a fundraising campaign? Sign up today to attend Life Science Nation’s Fundraising Bootcamp.  Pre-registration is required…

Read More
WIB-Capital Region Presents: HERstory Gala 2018: Honoring Outstanding Women in Biotech

WIB-Capital Region Presents: HERstory Gala 2018: Honoring Outstanding Women in Biotech

When:Thursday, December 13, 20187:00 p.m. – 10:00 p.m. EST Where:VisArts Rockville155 Gibbs StreetRockville, MD  20850United States The HERstory Gala is the premier event for…

Read More
Johns Hopkins researchers use deep learning to combat pancreatic cancer | Healthcare IT News

Johns Hopkins researchers use deep learning to combat pancreatic cancer | Healthcare IT News

Only 7 percent of patients live five years after diagnosis of pancreatic cancer, the lowest rate for any cancer, according to the American Cancer…

Read More
FDA approved the first-ever generic version of EpiPen – STAT

FDA approved the first-ever generic version of EpiPen – STAT

The Food and Drug Administration approved the first-ever generic version of EpiPen Thursday — a move the agency says could help lower costs for…

Read More
CAP Application Deadline Extended to August 23! – NIH SBIR/STTR

CAP Application Deadline Extended to August 23! – NIH SBIR/STTR

Does your small business need assistance in commercializing its HHS SBIR/STTR-funded technology? Was that technology developed with a Phase II HHS SBIR/STTR award that…

Read More
Profectus BioSciences, Emergent BioSolutions get $36 million to aid in new vaccine development – Baltimore Business Journal

Profectus BioSciences, Emergent BioSolutions get $36 million to aid in new vaccine development – Baltimore Business Journal

Maryland biotechnology firms Profectus BioSciences Inc. and Emergent BioSolutions Inc. will receive up to $36 million to develop and manufacture a new vaccine against…

Read More
BioNetworking: Fermenting Innovation – Sept 27th 3:00 PM

BioNetworking: Fermenting Innovation – Sept 27th 3:00 PM

This networking event is for BioTech Professionals in the BioHealth Capital Region. We encourage all professionals, post-docs and scientist to attend - it is…

Read More
Digital OMICS Innovators Meetup – Meetup

Digital OMICS Innovators Meetup – Meetup

Listen to, network with the hottest startup CXOs in the biohealth capital region at our first in a series of four annual meetups around…

Read More
A Harvard Scientist Thinks He Has a Gene Test for Heart Attack Risk. He Wants to Give It Away Free

A Harvard Scientist Thinks He Has a Gene Test for Heart Attack Risk. He Wants to Give It Away Free

A Harvard scientist thinks he's reached a new milestone: a genetic test that helps identify people who are at high risk of having a…

Read More
New MCEDC Website Features to Grow Your Business

New MCEDC Website Features to Grow Your Business

PROGRAMS AND INCENTIVES TO SPUR BUSINESS GROWTH We help you navigate available programs, grants and incentives to identify immediate opportunities and plan for long-term…

Read More
GlycoMimetics Receives Japanese Patent For Uproleselan (GMI-1271) – Business Wire

GlycoMimetics Receives Japanese Patent For Uproleselan (GMI-1271) – Business Wire

GlycoMimetics, Inc. (NASDAQ: GLYC), a biopharmaceutical company focused on discovering and developing novel small-molecule drug candidates to treat rare diseases, announced today that the…

Read More
Popper and Co. to Present New Framework for Economic Evaluation of Diagnostics in the Era of Precision Medicine at Next Generation Dx Summit

Popper and Co. to Present New Framework for Economic Evaluation of Diagnostics in the Era of Precision Medicine at Next Generation Dx Summit

Popper and Co., a strategy consulting and transaction advisory firm serving the needs of the medical technology and life sciences industries, announced today that…

Read More